- Home
- HXHX vs ALLR Comparison
HXHX vs ALLR Comparison
Compare HXHX & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- ALLR
- Stock Information
- Founded
- HXHX 2003
- ALLR 2004
- Country
- HXHX China
- ALLR United States
- Employees
- HXHX N/A
- ALLR N/A
- Industry
- HXHX Trucking Freight/Courier Services
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- ALLR Health Care
- Exchange
- HXHX Nasdaq
- ALLR Nasdaq
- Market Cap
- HXHX 13.3M
- ALLR 15.8M
- IPO Year
- HXHX 2025
- ALLR N/A
- Fundamental
- Price
- HXHX $1.36
- ALLR $1.66
- Analyst Decision
- HXHX
- ALLR Strong Buy
- Analyst Count
- HXHX 0
- ALLR 1
- Target Price
- HXHX N/A
- ALLR $9.00
- AVG Volume (30 Days)
- HXHX 222.9K
- ALLR 21.5M
- Earning Date
- HXHX 01-01-0001
- ALLR 08-15-2025
- Dividend Yield
- HXHX N/A
- ALLR N/A
- EPS Growth
- HXHX N/A
- ALLR N/A
- EPS
- HXHX 0.26
- ALLR N/A
- Revenue
- HXHX $25,571,810.00
- ALLR N/A
- Revenue This Year
- HXHX N/A
- ALLR N/A
- Revenue Next Year
- HXHX N/A
- ALLR N/A
- P/E Ratio
- HXHX $5.29
- ALLR N/A
- Revenue Growth
- HXHX N/A
- ALLR N/A
- 52 Week Low
- HXHX $0.84
- ALLR $0.61
- 52 Week High
- HXHX $6.29
- ALLR $3.91
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- ALLR 59.12
- Support Level
- HXHX N/A
- ALLR $1.78
- Resistance Level
- HXHX N/A
- ALLR $1.92
- Average True Range (ATR)
- HXHX 0.00
- ALLR 0.25
- MACD
- HXHX 0.00
- ALLR 0.02
- Stochastic Oscillator
- HXHX 0.00
- ALLR 52.25
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.